In a clinical trial setting, medication adherence is easy to assess. However, the same cannot be said for the real-world situation, where patient adherence becomes a behavioral construct. Digital and technological measures such as reminders via SMS, emails, and wearable devices have attempted to improve adherence but are subject to the willingness of the patient to comply. What are the feasible assessment criteria that can be used by payors and reimbursement authorities in the subject area of medication adherence to encourage innovation from industry?
I would appreciate having some reference articles or resources for additional knowledge.
- Badges
- Science topic
- Similar topics
- Psychology
- Mental Processes
- Learning
More Patrick Amponsah-Frempah's questions See All
Similar questions and discussions